- Aspenberg P, Schilcher J, Fahlgren A. Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Acta Orthop 2010; 81(4): 460–462.
- Bhandari M, Bajammal S, Guyatt GH, et al. Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. A meta-analysis. J Bone Joint Surg Am 2005; 87(2): 293–301.
- Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996; 348(9041): 1535–41.
- Chen F, Bhattacharyya T. Periprosthetic fracture of the femur after long-term bisphosphonate use. JBJS Case Connect 2012; 2(e21).
- Cross MB, Nam D, van der Meulen MC, Bostrom M PG. A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture. J Bone Joint Surg Br 2012; 94(7): 994–7.
- Curtin BM, Fehring TK. Bisphosphonate fractures as a cause of painful total hip arthroplasty. Orthopedics 2011; 34(12): 939–44.
- Goh SK, Yang KY, Koh JS, et al. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br 2007; 89(3): 349–53.
- Isaacs JD, Shidiak L, Harris IA, Szomor ZL. Femoral insufficiency fractures associated with prolonged bisphosphonate therapy. Clin Orthop Relat Res 2010; 468(12): 3384–92.
- Koeppen VA, Schilcher J, Aspenberg P. Dichotomous location of 160 atypical fractures. Acta Orthop 2013; 84(6): 561–4.
- Koh J SB, Goh SK, Png MA, Ng A CM, Howe TS. Distribution of atypical fractures and cortical stress lesions in the femur: implications on pathophysiology. Singapore Med J 2011; 52(2): 77–80.
- Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 2008; 22(5): 346–50.
- Saita Y, Ishijima M, Mogami A, et al. The fracture sites of atypical femoral fractures are associated with the weight-bearing lower limb alignment. Bone 2014; 66: 105–10.
- Sayed-Noor AS, Sjödén GO. Case reports: two femoral insufficiency fractures after long-term alendronate therapy. Clin Orthop Relat Res 2009; 467(7): 1921–6.
- Schaeffer JF, Attarian DE, Wellman SS. Periprosthetic femoral insufficiency fracture in a patient on long-term bisphosphonate therapy. The Duke Orthop J 2012; 2(1): 66–9.
- Schilcher J, Michaëlsson K, Aspenberg P. Bisphosphonate use and atypical fractures of the femoral shaft. N Eng J Med 2011; 364: 1728–37.
- Schilcher J, Koeppen V, Aspenberg P, Michaëlsson K. Risk of atypical femoral fracture during and after bisphosphonate use: Full report of a nationwide study. Acta Othop 2015; 86(1): 100–107.
- Shane E, Burr D, Ebeling PR, et al.; American Society for Bone and Mineral Research. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2010; 25(11): 2267–94.
- Shane E, Burr D, Abrahamsen B, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2014; 29(1): 1–23.
- Choose new content alerts to be informed about new research of interest to you
- Easy remote access to your institution's subscriptions on any device, from any location
- Save your searches and schedule alerts to send you new results
- Export your search results into a .csv file to support your research